Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Immune-related Adverse Event 1Esophageal Neoplasms 1Early Hormone Receptor-positive Breast Cancer 1

Interventions

Esophagectomy 9Radiotherapy 8Endoscopic Mucosal Resection 7Standard of Care 6Exercise 6Enteral Nutrition 6Endoscopy 6Magnetic Resonance Spectroscopy 5Fluorouracil 5Cisplatin 5Surveys and Questionnaires 4camrelizumab 3Yoga 3Radiofrequency Ablation 3Radiation 3Preoperative Exercise 3Practice Guidelines as Topic 3Fluorodeoxyglucose F18 3Chemoradiotherapy 3Blood Specimen Collection 3Biopsy 3spartalizumab 2X-Rays 2Robotic Surgical Procedures 2Psychosocial Intervention 2Psychiatric Rehabilitation 2Proton Therapy 2Physical Therapy Modalities 2Palliative Care 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Esophageal Neoplasms × Antineoplastic Agents × Clear all
NCT04688801 2022-11-16

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

The Second Hospital of Shandong University

Phase NA Recruiting
200 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡